consulting

Do you want to talk? My areas of expertise are broadly:

  • Gene therapy (AAV, CRISPR) construct and vector design, production, validation, testing (in vitro & in vivo).
  • Preclinical indication selection including clinical pathways & precedent, preclinical models, modality selection.
  • Disease expertise in Heart Failure with Preserved Ejection Fraction (HFpEF), Osteoarthritis (OA), Idiopathic Pulmonary Fibrosis (IPF), and Metabolism-Associated Steatohepatitis (MASH).
  • in vivo study design & validation and translational pipeline setup.
  • Impact philanthropy and new R&D mechanisms.